ReviewCellular & molecular immunology2015

IL-21 acts as a promising therapeutic target in systemic lupus erythematosus by regulating plasma cell differentiation.

Xiao-Mei Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.